SC 13D

Company

Pelthos Therapeutics Inc.

Filed

February 26, 2024

Accession Number

0001753926-24-000393

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →